Please use this identifier to cite or link to this item:
https://accedacris.ulpgc.es/jspui/handle/10553/134811
| Title: | Intracochlear Administration of DBOTO Gene Therapy in Pediatric Patients with Profound Hearing Loss Due to Otoferlin Mutations: The CHORD Phase 1/2 Open-Label Trial | Authors: | Lustig, Lawrence Bance, Manohar Ishiyama, Akira Nash, Robert Polo, Ruben Ramos De Miguel, Ángel Manrique Rodriguez, Manuel Jesus Rubinstein, Jay T. Quigley, Tera Riggs, Jason Corrales, Eduardo Anderson, Jeffery Valayannopoulos, Vassili |
UNESCO Clasification: | 32 Ciencias médicas 3201 Ciencias clínicas 320102 Genética clínica |
Issue Date: | 2024 | Journal: | Molecular Therapy | Conference: | ASGCT 27th Annual Meeting Abstracts | URI: | https://accedacris.ulpgc.es/handle/10553/134811 | ISSN: | 1525-0016 | Source: | Molecular Therapy[ISSN 1525-0016],v. 32 (4) sup. 1, p. 6, Abstract 10, (Abril 2024) |
| Appears in Collections: | Actas de congresos |
Page view(s)
199
checked on Sep 27, 2025
Download(s)
156
checked on Sep 27, 2025
Google ScholarTM
Check
Share
Export metadata
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.